Comparison of AFP and PIVKA-II level in different grades and stages of... | Download Table
IJMS | Free Full-Text | Immunological Markers, Prognostic Factors and Challenges Following Curative Treatments for Hepatocellular Carcinoma
Clinical value of serum AFP and PIVKA‐II for diagnosis, treatment and prognosis of hepatocellular carcinoma - Tian - 2023 - Journal of Clinical Laboratory Analysis - Wiley Online Library
Epitope characterization of an anti-PIVKA-II antibody and evaluation of a fully automated chemiluminescent immunoassay for PIVKA-II - ScienceDirect
Clinical utility of PIVKA-II in the diagnosis of hepatocellular carcinoma | Synnovis
Efficacy of PIVKA-II in prediction and early detection of hepatocellular carcinoma: a nested case-control study in Chinese patients | Scientific Reports
Clinical utility of PIVKA-II in the diagnosis of hepatocellular carcinoma | Synnovis
Significance of PIVKA‑II levels for predicting microvascular invasion and tumor cell proliferation in Chinese patients with hepatitis B virus‑associated hepatocellular carcinoma
Assessment of Pivka II as Tumour Marker in Hepatocellular Carcinoma
PIVKA-II serves as a potential biomarker that complements AFP for the diagnosis of hepatocellular carcinoma | BMC Cancer | Full Text
PIVKA-II, a biomarker of liver cells for the management of hepatocellular carcinoma (HCC) | Fujirebio
Medicina | Free Full-Text | Utility of PIVKA-II and AFP in Differentiating Hepatocellular Carcinoma from Non-Malignant High-Risk Patients
Clinical evaluation of Elecsys PIVKA-II for patients with advanced hepatocellular carcinoma | PLOS ONE
Role of PIVKA-II in screening for malignancies at a hepatobiliary and pancreatic disease center: A large-scale real-world study - ScienceDirect
Elecsys® PIVKA-II
PIVKA-II serves as a potential biomarker that complements AFP for the diagnosis of hepatocellular carcinoma | BMC Cancer | Full Text
Anti-h PIVKA-II 12102 SPTN-5
The diagnostic performance of PIVKA-II in metabolic and viral hepatocellular carcinoma: a pilot study
Effectiveness of PIVKA-II in the detection of hepatocellular carcinoma based on real-world clinical data | BMC Cancer | Full Text
Real impact of tumor marker AFP and PIVKA-II in detecting very small hepatocellular carcinoma (≤ 2 cm, Barcelona stage 0) - assessment with large number of cases
View of PIVKA-II or AFP has better diagnostic properties for hepatocellular carcinoma diagnosis in high-risk patients | Journal of Circulating Biomarkers